Up-regulation of Th1-type responses in mucosal leishmaniasis patients

Infection and Immunity

Volumn 70, Issue 12, 2002, Pages 6734-6740

  Bacellar, Olívia ^a   Lessa, Hélio ^a   Schriefer, Albert ^a   Machado, Paulo ^a   De Jesus, Amélia Ribeiro ^a   Dutra, Walderez O ^b   Gollob, Kenneth J ^b   Carvalho, Edgar M ^a,c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c HUPES   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; PARASITE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEISHMANIASIS; MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH1 CELL;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0036892847     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.12.6734-6740.2002     Document Type: Article

References (37)

1. Azulay, R. D., and D. R. Azulay, Jr. 1995. Immune-clinical-pathologic spectrum of leishmaniasis. Int. J. Dermatol. 34:303-307.
2. Bacellar, O., A. D'Oliveira, Jr., S. Jeronimo, and E. M. Carvalho. 2000. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12:1228-1231.
3. Barral, A., M. Barral-Netto, E. C. Yong, C. E. Brownell, D. R. Twardzik, and S. G. Reed. 1993. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 90:3442-3446.
4. Barral-Netto, M., A. Barral, C. Brodskyn, E. M. Carvalho, and S. G. Reed. 1995. Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunol. 17:21-28.
5. Barral-Netto, M., A. Barral, C. E. Brownell, Y. A. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-beta in leishmanial infection: A parasite escape mechanism. Science 257:545-548.
6. Bittencourt, A. L., and A. Barral. 1991. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem. Inst. Oswaldo Cruz Rio De J. 86:51-56.
7. Bottrel, R. L., W. O. Dutra, F. A. Martins, B. Gontijo, E. Carvalho, M. Barral-Netto, A. Barral, R. P. Almeida, W. Mayrink, R. Locksley, and K. J. Gollob. 2001. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble leishmania antigen in human cutaneous leishmaniasis. Infect. lmmun. 69:3232-3239.
8. Caceres-Dittmar, G., F. J. Tapia, M. A. Sanchez, M. Yamamura, K. Uyemura, R. L. Modlin, B. R. Bloom, and J. Convit. 1993. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin. Exp. lmmunol. 91:500-505.
9. Carvalho, E. M., O. Bacellar, A. Barral, R. Badaro, and W. D. Johnson, Jr. 1989. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J. Clin. Investig. 83:860-864.
10. Carvalho, E. M., O. Bacellar, C. Brownell, T. Regis, R. L. Coffman, and S. G. Reed. 1994. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152:5949-5956.
11. Carvalho, E. M., A. Barral, D. Pedral-Sampaio, M. Barral-Netto, R. Badaro, H. Rocha, and W. D. Johnson, Jr. 1992. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J. Infect. Dis. 165:535-540.
12. Carvalho, E. M., W. D. Johnson, E. Barreto, P. D. Marsden, J. L. Costa, S. Reed, and H. Rocha. 1985. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J. Immunol. 135:4144-4148.
13. Castes, M., A. Agnelli, and A. J. Rondon. 1984. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Clin. Exp. Immunol. 57:279-286.
14. Castes, M., A. Agnelli, O. Verde, and A. J. Rondon. 1983. Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin. Immunol. Immunopathol. 27:176-186.
15. Castes, M., D. Trujillo, M. E. Rojas, C. T. Fernandez, L. Araya, M. Cabrera, J. Blackwell, and J. Convit. 1993. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol. Res. 26:233-238.
16. Cuba Cuba, C. A., P. D. Marsden, A. C. Barreto, I. Roitman, A. Vexenat, L. M. de Lima, and M. H. de Sa. 1984. Identification of human stocks of Leishmania spp. isolated from patients with mucocutaneous leishmaniasis in Tres Bracos, Bahia, Brazil. Trans. R. Soc. Trop. Med. Hyg. 78:708-710.
17. Da Cruz, A. M., M. P. de Oliveira, P. M. De Luca, S. C. Mendonca, and S. G. Coutinho. 1996. Tumor necrosis factor-alpha in human American tegumentary leishmaniasis. Mem. Inst. Oswaldo Cruz Rio De J. 91:225-229.
18. Doherty, G. M., J. C. Jensen, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1991. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110:192-198.
19. Grau, G. E., P. F. Piguet, P. Vassalli, and P. H. Lambert. 1989. Tumornecrosis factor and other cytokines in cerebral malaria: Experimental and clinical data. Immunol. Rev. 112:49-70.
20. Ho, A. S., Y. Liu, T. A. Khan, D. H. Hsu, J. F. Bazan, and K. W. Moore. 1993. A receptor for interleukin 10 is related to interferon receptors. Proc. Natl. Acad. Sci. USA 90:11267-11271.
21. Lessa, H. A., P. Machado, F. Lima, A. A. Cruz, O. Bacellar, J. Guerreiro, and E. M. Carvalho. 2001. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am. J. Trop. Med. Hyg. 65:87-89.
22. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306-4310.
23. Liu, Y., S. H. Wei, A. S. Ho, R. de Waal Malefyt, and K. W. Moore. 1994. Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 152:1821-1829.
24. Marsden, P. D., and T. C. Jones. 1985. Clinical Manifestations, Diagnosis and Treatment of Leishmaniasis. Elsevier Science Publishers, Amsterdam, The Netherlands.
25. Michel, G., A. Mirmohammadsadegh, E. Olasz, B. Jarzebska-Deussen, A. Muschen, L. Kemeny, H. F. Abts, and T. Ruzicka. 1997. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: Decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes. J. Immunol. 159:6291-6297.
26. Othieno, C., C. S. Hirsch, B. D. Hamilton, K. Wilkinson, J. J. Ellner, and Z. Toossi. 1999. Interaction of Mycobacterium tuberculosis-induced transforming growth factor β1 and interleukin-10. Infect. Immun. 67:5730-5735.
27. Pirmez, C., M. Yamamura, K. Uyemura, M. Paes-Oliveira, F. Conceicao-Silva, and R. L. Modlin. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Investig. 91:1390-1395.
28. Reed, S. G., J. S. da Silva, J. L. Ho, J. K. Koehler, D. M. Russo, D. L. Pihl, and R. W. Coombs. 1992. Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoa. J. Acquir. Immune Defic. Syndr. 5:666-675.
29. Ribeiro-de-Jesus, A., R. P. Almeida, H. Lessa, O. Bacellar, and E. M. Carvalho. 1998. Cytokine profile and pathology in human leishmaniasis. Braz. J. Med. Biol. Res. 31:143-148.
30. Rocha, P. N., R. P. Almeida, O. Bacellar, A. R. de Jesus, D. C. Filho, A. C. Filho, A. Barral, R. L. Coffman, and E. M. Carvalho. 1999. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J. Infect. Dis. 180:1731-1734.
31. Russo, D. M., M. Barral-Netto, A. Barral, and S. G. Reed. 1993. Human T-cell responses in leishmania infections. Prog. Clin. Parasitol. 3:119-144.
32. Sarno, E. N., G. E. Grau, L. M. Vieira, and J. A. Nery. 1991. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin. Exp. Immunol, 84:103-108.
33. Schubach, A., M. C. Marzochi, T. Cuzzi-Maya, A. V. Oliveira, M. L. Araujo, A. L. Oliveira, R. S. Pacheco, H. Momen, F. Conceicao-Silva, S. G. Coutinho, and K. B. Marzochi. 1998. Cutaneous scars in American tegumentary leishmaniasis patients: A site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am. J. Trop. Med. Hyg. 58:824-827.
34. Skeiky, Y. A., D. R. Benson, J. A. Guderian, J. A. Whittle, O. Bacelar, E. M. Carvalho, and S. G. Reed. 1995. Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Infect. Immun. 63:4105-4114.
35. Skeiky, Y. A., J. A. Guderian, D. R. Benson, O. Bacelar, E. M. Carvalho, M. Kubin, R. Badaro, G. Trinchieri, and S. G. Reed. 1995. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J. Exp. Med. 181:1527-1537.
36. + T cells, analyzed at the single-cell level. J. Exp. Med. 184:473-483.
37. Stein, M., and S. Gordon. 1991. Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: Role of cell stimulation and specific phagocytic plasma membrane receptors. Eur. J. Immunol. 21:431-437.